http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010210892-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_938a6d7a15cbc93a74abe1953eb25d47 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2531-113 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-707 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da66bae273ff3eafda358d7a7540cba5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_495c75cfa7c6fa89df92b494f0b5bdd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60a58890a160f52b36cce9120cfe2ee0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05dfae520589e4ffca3c272a45d654bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc63f2c2fda8f271ad14fa5dd35e5455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e47b7b665b1bd6de8c31ffa82d0ca1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8713a982b279571412ca9a36b85d4a74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af0450d59b70c7b28a9f4961cfbee49c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e262c7c6e474d38cd9e5a1081341b93c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1d54e47758b5336461f5a8b6fc7527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b4f54ebff9ee1150ebb3bc96ce84b2b |
| publicationDate | 2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2010210892-A1 |
| titleOfInvention | Methods for amplifying Hepatitis C virus nucleic acids |
| abstract | A method of amplifying an HCV nucleic acid in an HCV infected sample comprises amplifying a segment of a DNA template that is complementary to a genome of HCV RNA from the sample by a two-stage PCR, wherein a first stage PCR employs a first outer primer and a second outer primer, and a second stage PCR employs a first inner primer and a second inner primer. The nucleotide sequence of the first outer primer comprises a nucleotide sequence as set forth in SEQ ID NO: 2; or SEQ ID NO:9, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 9. The nucleotide sequence of the second outer primer comprises a nucleotide sequence set forth in SEQ ID NO: 3 or 4; or a nucleotide sequence as set forth in SEQ ID NO: 10 or 11, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 10 and 11. The nucleotide sequence of the first inner primer comprises a nucleotide sequence as set forth in SEQ ID NO: 5; or SEQ ID NO: 12, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 12. The nucleotide sequence of the second inner primer comprises a nucleotide sequence as set forth in SEQ ID NO: 6 or 7; or a nucleotide sequence as set forth in SEQ ID NO: 13 or 14, wherein optionally 1, 2 or 3 nucleotides are other nucleotides than those of SEQ ID NO: 13 and 14. |
| priorityDate | 2009-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 198.